Aroa Biosurgery Limited (AROAF)
OTCMKTS · Delayed Price · Currency is USD
0.5220
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Aroa Biosurgery Revenue
Aroa Biosurgery had revenue of 44.86M NZD in the half year ending September 30, 2025, with 40.75% growth. This brings the company's revenue in the last twelve months to 90.40M, up 18.40% year-over-year. In the fiscal year ending March 31, 2025, Aroa Biosurgery had annual revenue of 84.70M with 22.63% growth.
Revenue (ttm)
90.40M NZD
Revenue Growth
+18.40%
P/S Ratio
3.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
171.54M USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 84.70M | 15.63M | 22.63% |
| Mar 31, 2024 | 69.07M | 5.71M | 9.01% |
| Mar 31, 2023 | 63.36M | 23.68M | 59.68% |
| Mar 31, 2022 | 39.68M | 17.34M | 77.60% |
| Mar 31, 2021 | 22.34M | -2.73M | -10.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |